What will you find at Conscio booth?

We will showcase a broad range of services that cover the entire pharmaceutical lifecycle:

  • Formulation development
  • Analytical R&D
  • GMP manufacturing of IMPs
  • Clinical trials and bioanalytical testing
  • Quality control of small molecules and biologics
  • Post-approval and regulatory support

We will be happy to discuss your projects over a freshly prepared coffee or artisan tea.

You will also have the opportunity to meet our strategic partner and trusted representative in the USA – Kiel Laboratories, specialists in bringing new drugs to market, particularly through the 505(b)(2) pathway for FDA approval. We are pleased to welcome them at our booth again.

If you’re interested in arranging a meeting with us, please reach out to your business representative or send an email to sales@quinta.cz, and we will schedule a time slot for you.

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.

ALL POSTS